Search Results 951-960 of 16760 for astragalus dosage

  1. A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy - Mayo Clinic

    ... dosing schedule, maximum tolerated dose (MTD), and the recommended phase two dose (RPTD) of ABT-199 when administered in subjects with relapsed /refactory ...

  2. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma. Patient ...

  3. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    Participation eligibility · Corticosteroids. Active disease despite a history of at least an induction regimen of a dose equivalent to oral prednisone 30 mg ...

  4. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients - Mayo Clinic

    About this study. Primary Objective: To demonstrate the benefit of isatuximab in combination with pomalidomide and low-dose dexamethasone in the ...

  5. Clinical trials - Oncology (Medical)

    ... dose and embolic load. The Patient Group 2 primary objectives are to assess the association of circulating and imaging biomarkers on Future Liver Remnant ...

  6. Clinical trials - Oncology (Medical)

    Correlate this measurement with mean lobar absorbed radiation dose and embolic load given to patients and time taken to achieve adequate Future Liver Remnant (> ...

  7. Oncology (Medical) - Clinical trials

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  8. Neurosciences Clinical Trials - Medical Professionals

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  9. Flortaucipir f 18 (intravenous route) - Mayo Clinic

    This product is available in the following dosage forms: Solution. Back to top. Before Using. In deciding to use a diagnostic test, any risks of the test must ...

  10. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety, disease response, and drug /body interactions of rSIFN-co at different dose levels to demonstrate optimal ...